InsidersTradesSigma
Browse the full directors' dealings record of 동성제약, a listed equity based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Market capitalisation: €105.9bn. The latest transaction was reported on 15 April 2026 — Purchase. Among the most active insiders: 유암코제약산업제1호기업재무안정사모투자. All data is openly available.
FY ended December 2025 · cache
0 of 0 declarations